|
| 36269846 | The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. | Blood Adv | 2023 |
| 37603350 | Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. | Blood Adv | 2023 |
| 37969120 | Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/<i>KMT2A</i> alterations. | Transl Pediatr | 2023 |
| 37196637 | Association of social deprivation with survival in younger adult patients with AML: an Alliance study. | Blood Adv | 2023 |
| 36823396 | Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. | Leukemia | 2023 |
| 34261293 | Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia. | Haematologica | 2022 |
| 35349669 | Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia. | Blood Adv | 2022 |
| 35792553 | Controlled variable selection in Weibull mixture cure models for high-dimensional data. | Stat Med | 2022 |
| 35788257 | High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. | Blood Adv | 2022 |
| 35848612 | Molecular cytogenetics in acute myeloid leukemia in adult patients: practical implications. | Pol Arch Intern Med | 2022 |
| 36184192 | High-dimensional genomic feature selection with the ordered stereotype logit model. | Brief Bioinform | 2022 |
| 34847232 | Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia. | Blood Adv | 2022 |
| 32926565 | Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure. | Int J Lab Hematol | 2021 |
| 33683341 | Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia. | Blood Adv | 2021 |
| 34863095 | Discovery of clinically relevant fusions in pediatric cancer. | BMC Genomics | 2021 |
| 34732719 | Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia. | Nat Commun | 2021 |
| 34251414 | Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance). | Blood Adv | 2021 |
| 34003250 | Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21). | Blood Adv | 2021 |
| 34229733 | Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement. | J Hematol Oncol | 2021 |
| 33277314 | Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia. | Cancer Discov | 2021 |
| 31462731 | Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21. | Leukemia | 2020 |
| 31945158 | Clinical and functional significance of circular RNAs in cytogenetically normal AML. | Blood Adv | 2020 |
| 31911614 | Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. | Nat Commun | 2020 |
| 32092139 | Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801. | Blood Adv | 2020 |
| 32728019 | Author Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. | Nat Commun | 2020 |
| 33020282 | Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/<i>KMT2A</i>. | Proc Natl Acad Sci U S A | 2020 |
| 32461631 | Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia agedâ¿¿<60 years. | Leukemia | 2020 |
| 31413100 | Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia. | Haematologica | 2020 |
| 30658992 | A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. | Blood | 2019 |
| 31767858 | The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. | Nat Commun | 2019 |
| 31375516 | Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia. | Clin Cancer Res | 2019 |
| 31073153 | Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. | Leukemia | 2019 |
| 30737482 | Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. | Leukemia | 2019 |
| 30858548 | Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells. | Leukemia | 2019 |
| 31164409 | Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia. | Mol Cancer Ther | 2019 |
| 30679803 | Implementation of standardized variant-calling nomenclature in the age of next-generation sequencing: where do we stand? | Leukemia | 2019 |
| 30291333 | Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA. | Leukemia | 2019 |
| 30643249 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. | Nat Genet | 2019 |
| 29563537 | Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies. | Leukemia | 2018 |
| 29991495 | Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission. | Blood Adv | 2018 |
| 30117318 | Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit). | Cancer Med | 2018 |
| 29872168 | NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. | Leukemia | 2018 |
| 30567725 | Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance). | Blood Adv | 2018 |
| 27624549 | Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503). | Leukemia | 2017 |
| 28336936 | No evidence for microsatellite instability in acute myeloid leukemia. | Leukemia | 2017 |
| 28133783 | Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation. | Am J Hematol | 2017 |
| 28473620 | Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. | Haematologica | 2017 |
| 28321123 | The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia. | Leukemia | 2017 |
| 28533390 | Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2017 |
| 27843138 | Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia. | Leukemia | 2017 |